ClinicalTrials.gg
Drug

Dexamethasone clinical trials

Also written Decadron, Hexadrol, Dexametasone and ISV-305.

Includes 66 studies of Dexamethasone phosphate, 34 studies of Dexamethasone Intravitreal Implant and 12 studies of Dexamethasone acetate.

studies test it
1,793
open now
269
in phase 3
343
first study started
1990
Related medicines add 11 studies

Counted the way a researcher would: Dexamethasone with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.

This browser remembers your choice.

How each study uses Dexamethasone is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Dexamethasone studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
30 Oct 1958 · DECADRON · NDA 011664 (FDA, Drugs@FDA)
European Union
26 Jul 2010 · Ozurdex · EMEA/H/C/001140 (EMA; as Dexamethasone Intravitreal Implant)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Dexamethasone
1,168
DM
25
DXM
24
Dexamethasone 4mg
21
Dexamethasone Oral
20

Brand

Decadron
204
Hexadrol
21
Ozurdex
21
Aeroseb-Dex
21
Decaderm
21
Dextenza
20
Dexasone
18
Maxidex
13

Development codes

ISV-305
3
NSC-34521
2
CI632D
1
Dex 21P
1
KTX-1001
1
EACODD-14
1

Other names

Dexametasone
4
hexadecadrol
3
Gammacorten
1
Millicorten
1
Visumetazone
1

In one entry with another drug

Given together, or one or the other

OTO-104
9
Lenalidomide and dexamethasone
6
Bupivacaine + Dexamethasone
4
Bupivacaine with Dexamethasone
4
Dexamethasone and dexmedetomidine
3
Ropivacaine and Dexamethasone
3
Bupivacaine and dexamethasone
3
Ropivacaine + dexamethasone
3

Studies by the year they started

1,783 studies that test it; most in 2021 (129); 4 more planned to start later

Studies that test Dexamethasone, by start year
YearStudies
19901
19921
19932
19955
19965
19973
199810
19995
200015
20019
200225
200324
200426
200536
200642
200740
200851
200952
201057
201153
201255
201373
201479
201582
2016105
2017102
2018103
201983
2020108
2021129
202278
202372
202484
202580
202688

By phase

A phase 1/2 study counts in both.

Early Phase 1
33
Phase 1
223
Phase 2
637
Phase 3
343
Phase 4
440
No phase
257

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 197 · Other 1,596

Assiut University (41) · M.D. Anderson Cancer Center (36) · Mayo Clinic (33) · Poznan University of Medical Sciences (24) · Memorial Sloan Kettering Cancer Center (23) · Ain Shams University (21) · National Cancer Institute (NCI) (18) · Allergan (18)

Often tested with

Tested in the same studies.

Lenalidomide (170) · Bortezomib (154) · Cyclophosphamide (129) · Daratumumab (70) · Carfilzomib (69) · Pomalidomide (68) · Doxorubicin (67) · Vincristine (63)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 30 phase 3 studies under way

Dexamethasone is the comparator. A study of two new drugs counts under both.

  • 3Elranatamab · Pfizer · next primary completion Oct 2030
  • 2Ramantamig · Janssen Research & Development, LLC · next primary completion Sep 2030
  • 2Linvoseltamab · Regeneron Pharmaceuticals · next primary completion Apr 2033
  • 2Etentamig · AbbVie · next primary completion Feb 2033
  • 2Teclistamab · Janssen Research & Development, LLC, University of Leeds · next primary completion Apr 2031
  • 2Talquetamab · Janssen Research & Development, LLC, University of Leeds · next primary completion Apr 2031
  • 2Daratumumab · Pfizer · next primary completion Oct 2030
  • 1Equecabtagene autoleucel · Nanjing IASO Biotechnology Co., Ltd. · next primary completion Aug 2027
Reaching primary completion within a year · 112, 13 in phase 3

Studies that test Dexamethasone, phase 3 first.

Studies

Open first, then newest update. How each study uses Dexamethasone is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 1,793

See all 1,793 studies that test Dexamethasone →

Given beside what is tested · 929 — Dexamethasone is usual care or a partner of the new treatment

Showing 20 of 929.

As the comparator · 150 — what is tested is compared with Dexamethasone

Showing 20 of 150.

What changed recently

From the registry's own updates since Oct 17, 2026.

Codes

What other systems call Dexamethasone · ClinicalTrials.gg INT007323

  • MeSH (NLM) D003907DexamethasoneConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 7S5I7G3JQLDEXAMETHASONEConfirmed FDA, NLM, Wikidata
  • RxNorm 3264Confirmed FDA, Wikidata
  • Wikidata Q422252dexamethasoneConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C422DexamethasoneOne source FDA
  • DrugBank DB01234One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.